{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T21:05:01Z","timestamp":1743368701696,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201550"],"award-info":[{"award-number":["82201550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10072-024-07518-4","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T08:02:01Z","timestamp":1713859321000},"page":"2969-2976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China"],"prefix":"10.1007","volume":"45","author":[{"given":"Jiayi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-3060","authenticated-orcid":false,"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"7518_CR1","doi-asserted-by":"crossref","unstructured":"Safiabadi Tali SH et al (2021) Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection. Clin Microbiol Rev 34(3):e00228\u201320","DOI":"10.1128\/CMR.00228-20"},{"issue":"1","key":"7518_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12992-022-00804-w","volume":"18","author":"H Feng","year":"2022","unstructured":"Feng H et al (2022) COVID-19, sex, and gender in China: a scoping review. Glob Health 18(1):9","journal-title":"Glob Health"},{"issue":"11","key":"7518_CR3","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","volume":"41","author":"VK Paliwal","year":"2020","unstructured":"Paliwal VK et al (2020) Neuromuscular presentations in patients with COVID-19. Neurol Sci 41(11):3039\u20133056","journal-title":"Neurol Sci"},{"issue":"6","key":"7518_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ et al (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20(6):363\u2013374","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"7518_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H (2020) Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol 30(6):1\u20139","journal-title":"Rev Med Virol"},{"issue":"5","key":"7518_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/WCO.0000000000000970","volume":"34","author":"J Suh","year":"2021","unstructured":"Suh J, Amato AA (2021) Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol 34(5):669\u2013674","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"7518_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmv.27292","volume":"94","author":"N Yazdanpanah","year":"2022","unstructured":"Yazdanpanah N, Rezaei N (2022) Autoimmune complications of COVID-19. J Med Virol 94(1):54\u201362","journal-title":"J Med Virol"},{"issue":"12","key":"7518_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","volume":"19","author":"S Muppidi","year":"2020","unstructured":"Muppidi S et al (2020) COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). Lancet Neurol 19(12):970\u2013971","journal-title":"Lancet Neurol"},{"issue":"1","key":"7518_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","volume":"58","author":"D Tugasworo","year":"2022","unstructured":"Tugasworo D et al (2022) The relationship between myasthenia gravis and COVID-19: a systematic review. Egypt J Neurol Psychiatr Neurosurg 58(1):83","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"26","key":"7518_CR10","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375(26):2570\u20132581","journal-title":"N Engl J Med"},{"issue":"1","key":"7518_CR11","first-page":"41","volume":"7","author":"YH Jin","year":"2020","unstructured":"Jin YH et al (2020) Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version). Mil Med Res 7(1):41","journal-title":"Mil Med Res"},{"issue":"7","key":"7518_CR12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI et al (1999) Myasthenia gravis activities of daily living profile. Neurology 52(7):1487\u20131489","journal-title":"Neurology"},{"issue":"2","key":"7518_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/neurolint14020033","volume":"14","author":"A Lupica","year":"2022","unstructured":"Lupica A et al (2022) Impact of COVID-19 in AChR myasthenia gravis and the safety of vaccines: data from an Italian cohort. Neurol Int 14(2):406\u2013416","journal-title":"Neurol Int"},{"key":"7518_CR14","doi-asserted-by":"publisher","first-page":"107441","DOI":"10.1016\/j.clineuro.2022.107441","volume":"222","author":"N Karimi","year":"2022","unstructured":"Karimi N et al (2022) Clinical features and outcomes of patients with myasthenia gravis affected by COVID-19: a single-center study. Clin Neurol Neurosurg 222:107441","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"7518_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mus.26918","volume":"62","author":"P Anand","year":"2020","unstructured":"Anand P et al (2020) COVID-19 in patients with myasthenia gravis. Muscle Nerve 62(2):254\u2013258","journal-title":"Muscle Nerve"},{"issue":"6","key":"7518_CR16","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.4103\/0028-3886.333460","volume":"69","author":"JMK Murthy","year":"2021","unstructured":"Murthy JMK et al (2021) COVID-19 in patients with myasthenia gravis: mechanisms of respiratory failure. Neurol India 69(6):1772\u20131776","journal-title":"Neurol India"},{"issue":"3","key":"7518_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.22551\/2022.36.0903.10212","volume":"9","author":"CG Croitoru","year":"2022","unstructured":"Croitoru CG et al (2022) Autoimmune myasthenia gravis after COVID-19 in a triple vaccinated patient. Arch Clin Cases 9(3):104\u2013107","journal-title":"Arch Clin Cases"},{"issue":"6","key":"7518_CR18","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.4103\/aian.aian_470_22","volume":"25","author":"B \u00d6zen\u00e7","year":"2022","unstructured":"\u00d6zen\u00e7 B, Odaba\u015f\u0131 Z (2022) New-onset myasthenia gravis following COVID-19 vaccination. Ann Indian Acad Neurol 25(6):1224\u20131225","journal-title":"Ann Indian Acad Neurol"},{"key":"7518_CR19","doi-asserted-by":"crossref","unstructured":"Ruan Z et al (2021) COVID-19 vaccination in patients with myasthenia gravis: a single-center case series. Vaccines (Basel) 9(10):1112","DOI":"10.3390\/vaccines9101112"},{"issue":"8","key":"7518_CR20","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1111\/ene.15348","volume":"29","author":"A Farina","year":"2022","unstructured":"Farina A et al (2022) Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: a multicenter experience. Eur J Neurol 29(8):2505\u20132510","journal-title":"Eur J Neurol"},{"issue":"5","key":"7518_CR21","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/mus.27703","volume":"66","author":"J Gamez","year":"2022","unstructured":"Gamez J, Gamez A, Carmona F (2022) Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis. Muscle Nerve 66(5):612\u2013617","journal-title":"Muscle Nerve"},{"issue":"4","key":"7518_CR22","doi-asserted-by":"publisher","first-page":"e239834","DOI":"10.1001\/jamanetworkopen.2023.9834","volume":"6","author":"M Alcantara","year":"2023","unstructured":"Alcantara M et al (2023) Outcomes of COVID-19 infection and vaccination among individuals with myasthenia gravis. JAMA Netw Open 6(4):e239834","journal-title":"JAMA Netw Open"},{"issue":"12","key":"7518_CR23","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1007\/s00415-022-11303-8","volume":"269","author":"A Doron","year":"2022","unstructured":"Doron A et al (2022) BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves. J Neurol 269(12):6193\u20136201","journal-title":"J Neurol"},{"issue":"10359","key":"7518_CR24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"CKH Wong","year":"2022","unstructured":"Wong CKH et al (2022) Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet 400(10359):1213\u20131222","journal-title":"Lancet"},{"issue":"8","key":"7518_CR25","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1473-3099(22)00119-0","volume":"22","author":"R Dal-R\u00e9","year":"2022","unstructured":"Dal-R\u00e9 R et al (2022) Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach. Lancet Infect Dis 22(8):e231\u2013e238","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"7518_CR26","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1111\/ene.14951","volume":"28","author":"M Jakub\u00edkov\u00e1","year":"2021","unstructured":"Jakub\u00edkov\u00e1 M et al (2021) Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol 28(10):3418\u20133425","journal-title":"Eur J Neurol"},{"issue":"1","key":"7518_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/1471-2105-15-333","volume":"15","author":"MA Moni","year":"2014","unstructured":"Moni MA, Li\u00f2 P (2014) Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies. BMC Bioinformatics 15(1):333","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"7518_CR28","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s40618-021-01554-z","volume":"44","author":"G Lisco","year":"2021","unstructured":"Lisco G et al (2021) Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Invest 44(9):1801\u20131814","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"7518_CR29","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2213-2600(20)30239-3","volume":"8","author":"RN van Zyl-Smit","year":"2020","unstructured":"van Zyl-Smit RN, Richards G, Leone FT (2020) Tobacco smoking and COVID-19 infection. Lancet Respir Med 8(7):664\u2013665","journal-title":"Lancet Respir Med"},{"issue":"16","key":"7518_CR30","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000011669","volume":"96","author":"G Sol\u00e9","year":"2021","unstructured":"Sol\u00e9 G et al (2021) Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis. Neurology 96(16):e2109\u2013e2120","journal-title":"Neurology"},{"issue":"10","key":"7518_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.nmd.2022.09.002","volume":"32","author":"L Remijn-Nelissen","year":"2022","unstructured":"Remijn-Nelissen L, Verschuuren JJGM, Tannemaat MR (2022) The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study. Neuromuscul Disord 32(10):790\u2013799","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"7518_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-022-11389-0","volume":"270","author":"F Stascheit","year":"2023","unstructured":"Stascheit F et al (2023) Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis. J Neurol 270(1):1\u201312","journal-title":"J Neurol"},{"issue":"2","key":"7518_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mus.27324","volume":"64","author":"P Businaro","year":"2021","unstructured":"Businaro P et al (2021) COVID-19 in patients with myasthenia gravis: epidemiology and disease course. Muscle Nerve 64(2):206\u2013211","journal-title":"Muscle Nerve"},{"key":"7518_CR34","doi-asserted-by":"publisher","first-page":"117230","DOI":"10.1016\/j.jns.2020.117230","volume":"420","author":"S Kovvuru","year":"2021","unstructured":"Kovvuru S et al (2021) Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic. J Neurol Sci 420:117230","journal-title":"J Neurol Sci"},{"key":"7518_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE et al (2020) Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol 11:1053","journal-title":"Front Neurol"},{"issue":"3","key":"7518_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.nmd.2023.02.005","volume":"33","author":"V Damato","year":"2023","unstructured":"Damato V et al (2023) Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with rituximab. Neuromuscul Disord 33(3):288\u2013294","journal-title":"Neuromuscul Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07518-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07518-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07518-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T01:07:46Z","timestamp":1718327266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07518-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["7518"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07518-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"5 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking University First Hospital, and informed consent was obtained from all patients or their family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}